CID 71594828
Daclastavir
Structural Information
- Molecular Formula
- C41H52N8O6
- SMILES
- CC(C)[C@H](CNC(=O)OC)C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC
- InChI
- InChI=1S/C41H52N8O6/c1-24(2)30(21-44-40(52)54-5)38(50)48-19-7-9-33(48)36-42-22-31(45-36)28-15-11-26(12-16-28)27-13-17-29(18-14-27)32-23-43-37(46-32)34-10-8-20-49(34)39(51)35(25(3)4)47-41(53)55-6/h11-18,22-25,30,33-35H,7-10,19-21H2,1-6H3,(H,42,45)(H,43,46)(H,44,52)(H,47,53)/t30-,33?,34?,35-/m0/s1
- InChIKey
- OVPGYLMBPQNZNE-DAVBBFPVSA-N
- Compound name
- methyl N-[(2R)-2-[2-[5-[4-[4-[2-[1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carbonyl]-3-methylbutyl]carbamate
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 753.40828 | 266.3 |
[M+Na]+ | 775.39022 | 274.2 |
[M+NH4]+ | 770.43482 | 271.1 |
[M+K]+ | 791.36416 | 269.2 |
[M-H]- | 751.39372 | 266.1 |
[M+Na-2H]- | 773.37567 | 270.4 |
[M]+ | 752.40045 | 269.7 |
[M]- | 752.40155 | 269.7 |
Literature stripe
Patent stripe
No patent data available for this compound.